Rhenman & Partners Asset Management’s Epizyme, Inc EPZM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-265,000	Closed	-$702K	–	96
2021 Q4	$702K	Hold	265,000	–	–	0.05%	91
2021 Q3	$1.36M	Hold	265,000	–	–	0.1%	90
2021 Q2	$2.2M	Hold	265,000	–	–	0.15%	91
2021 Q1	$2.31M	Hold	265,000	–	–	0.16%	91
2020 Q4	$2.88M	Hold	265,000	–	–	0.23%	76
2020 Q3	$3.16M	Hold	265,000	–	–	0.28%	71
2020 Q2	$4.26M	Sell	265,000 -85,000	-24%	-$1.48M	0.46%	68
2020 Q1	$5.43M	Sell	350,000 -75,000	-18%	-$1.61M	0.76%	50
2019 Q4	$10.5M	Sell	425,000 -25,028	-6%	-$372K	1.15%	36
2019 Q3	$4.64M	Sell	450,028 -43,651	-9%	-$551K	0.58%	58
2019 Q2	$6.2M	Buy	493,679 +434,474	+734%	+$5.59M	0.68%	54
2019 Q1	$734K	Buy	+59,205	New	+$662K	0.09%	75
2018 Q2	–	Sell	-181,291	Closed	-$3.22M	–	92
2018 Q1	$3.22M	Sell	181,291 -36,300	-17%	-$613K	0.4%	63
2017 Q4	$2.73M	Sell	217,591 -18,702	-8%	-$272K	0.37%	68
2017 Q3	$4.5M	Sell	236,293 -15,843	-6%	-$242K	0.57%	61
2017 Q2	$3.81M	Buy	+252,136	New	+$3.81M	0.55%	65
2015 Q3	–	Sell	-131,785	Closed	-$3.16M	–	101
2015 Q2	$3.16M	Buy	+131,785	New	+$2.54M	0.45%	79